13F filing recap · Q4 2017

What did Abrams Capital Management buy in Q4 2017?

Reported stock-position changes between this filing and the previous one.

Stock value

$2.97B

Positions

Estimated turnover

20.3%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

TWXTime Warner Inc$272.64Mreported value+2.98M shares PCGPG&E Corp$145.70Mreported value+3.25M shares

Increased positions

ORLYO Reilly Automotive Inc$212.44Mreported value+29.2K shares+3.4%QCPQuality Care Properties Inc$70.12Mreported value+77.5K shares+1.6%ABGAsbury Automotive Group, Inc.$69.45Mreported value+85.1K shares+8.5%KERXKeryx Biopharmaceuticals Inc$45.19Mreported value+4.00M shares

Reduced positions

TEVATeva Pharmaceutical Industries Limited$374.13Mreported value-1.88M shares-8.7%WFCWells Fargo & Company/mn$173.74Mreported value-478.7K shares-14.3%CLNSColony Northstar Inc$55.77Mreported value-802.5K shares-14.1%BNEDBarnes & Noble Education, Inc.$53.89Mreported value-2.23M shares